ZBH - Company ID 0001136869
The table below shows ZIMMER BIOMET HOLDINGS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $359.40M | $382.80M | $228.00M | $307.70M | - | $246.50M |
| Capital expenditure | $36.30M | $44.60M | $55.10M | $46.70M | $36.40M | $25.80M |
| Investing cash flow | -$159.00M | -$106.00M | -$195.00M | -$149.40M | - | -$122.30M |
| Dividends paid | $46.90M | $47.80M | $49.40M | $50.30M |
ZIMMER BIOMET HOLDINGS, INC. reported operating cash flow of $1.70B for fiscal year 2025. That is up 13.2% from $1.50B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $963.10M (FY 2013) to $1.70B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $50.20M |
| $49.80M |
| Stock buybacks | $250.10M | $229.80M | $113.60M | $267.60M | - | - |
| Financing cash flow | -$369.20M | $575.40M | -$50.10M | -$206.70M | - | -$195.80M |